Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126822431 | 12682243 | 1 | I | 20160722 | 20160824 | 20160824 | EXP | US-AMGEN-USASL2016095897 | AMGEN | 78.00 | YR | E | M | Y | 68.27000 | KG | 20160824 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126822431 | 12682243 | 1 | PS | PROCRIT | ERYTHROPOIETIN | 1 | Unknown | UNK | U | 103234 | SOLUTION FOR INJECTION | ||||||||
| 126822431 | 12682243 | 2 | SS | PROCRIT | ERYTHROPOIETIN | 1 | Unknown | 10,000, UNK, UNK | U | G223021A | 103234 | SOLUTION FOR INJECTION | |||||||
| 126822431 | 12682243 | 3 | SS | PROCRIT | ERYTHROPOIETIN | 1 | Unknown | 10,000, UNK, UNK | U | G223021A | 103234 | SOLUTION FOR INJECTION | |||||||
| 126822431 | 12682243 | 4 | SS | PROCRIT | ERYTHROPOIETIN | 1 | Unknown | 10,000, UNK, UNK | U | G223021A | 103234 | SOLUTION FOR INJECTION | |||||||
| 126822431 | 12682243 | 5 | SS | PROCRIT | ERYTHROPOIETIN | 1 | Unknown | 20,000, UNK, UNK | U | G262419A | 103234 | SOLUTION FOR INJECTION | |||||||
| 126822431 | 12682243 | 6 | SS | PROCRIT | ERYTHROPOIETIN | 1 | Unknown | 20,000, UNK, UNK | U | G2624418A | 103234 | SOLUTION FOR INJECTION | |||||||
| 126822431 | 12682243 | 7 | SS | PROCRIT | ERYTHROPOIETIN | 1 | Unknown | 20,000, UNK, UNK | U | G262416A | 103234 | SOLUTION FOR INJECTION | |||||||
| 126822431 | 12682243 | 8 | SS | PROCRIT | ERYTHROPOIETIN | 1 | Unknown | 20,000 UNIT/ML, EVERY 4 WEEKS | U | 103234 | SOLUTION FOR INJECTION | ||||||||
| 126822431 | 12682243 | 9 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | Oral | 5 MG, 1 TABLET BY 90 TABLET NIGHTLY | 0 | 5 | MG | TABLET | QD | ||||||
| 126822431 | 12682243 | 10 | C | RENVELA | SEVELAMER CARBONATE | 1 | Oral | 800 MG, 1 TABLET BY 180 TABLET TWICE A DAY, TAKE WITH MEALS | 0 | 800 | MG | TABLET | BID | ||||||
| 126822431 | 12682243 | 11 | C | SODIUM BICARBONATE. | SODIUM BICARBONATE | 1 | 650 MG, FOUR TABLETS TWICE A DAY | 0 | 650 | MG | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126822431 | 12682243 | 1 | Nephrogenic anaemia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126822431 | 12682243 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126822431 | 12682243 | Blood urea increased | |
| 126822431 | 12682243 | Dialysis | |
| 126822431 | 12682243 | Diverticulum | |
| 126822431 | 12682243 | End stage renal disease | |
| 126822431 | 12682243 | Fall | |
| 126822431 | 12682243 | Feeling abnormal | |
| 126822431 | 12682243 | Gait disturbance | |
| 126822431 | 12682243 | Gastrointestinal haemorrhage | |
| 126822431 | 12682243 | Haematoma | |
| 126822431 | 12682243 | Neuropathy peripheral |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126822431 | 12682243 | 2 | 20151209 | 0 | ||
| 126822431 | 12682243 | 3 | 20160115 | 0 | ||
| 126822431 | 12682243 | 4 | 20160407 | 0 | ||
| 126822431 | 12682243 | 5 | 20160512 | 0 | ||
| 126822431 | 12682243 | 6 | 20160616 | 0 | ||
| 126822431 | 12682243 | 7 | 20160627 | 0 | ||
| 126822431 | 12682243 | 8 | 20160711 | 0 | ||
| 126822431 | 12682243 | 9 | 20160425 | 0 | ||
| 126822431 | 12682243 | 10 | 20160302 | 0 |